News
Mixed data from lung cancer trials on show at WCLC
Highlights of the WCLC show include new data for AstraZeneca's Tagrisso, Summit's ivonescimab, MSD/Daiichi's I-DXd, and BMS/Systimmune's iza-bren.
News
NRG raises £50m to start trials of Parkinson's, ALS drug
NRG Therapeutics' oversubscribed Series B will fund first-in-human trials of a drug targeting mitochondrial dysfunction in neurodegenerative diseases.
News
Servier bets $450m on Fragile X syndrome drug
Servier has pushed its emerging neurology pipeline into the clinical trials stage by licensing a drug for Fragile X syndrome from the UK's Kaerus.
R&D
Navigating the unique challenges of epilepsy in women's heal...
Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.
News
FDA releases previously unseen CRLs in transparency push
The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
